Zurueck zur Suche

Reporte zur Charge AU3130B

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

8Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MN 3 CA 1 NC 1 TX 1 KS 1 WA 1

VAERS 2693935

SEQIRUS, INC. · INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT) · Charge AU3130B

schwer
Staat
CA
Alter
19,0
Geschlecht
F
Eingang
10.10.2023
Impfdatum
10.10.2023
Beginn
10.10.2023
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Confusional state Dizziness Hemiparesis Hypoaesthesia Mobility decreased Seizure Vision blurred

Symptomtext

After a few minutes after receiving vaccine, patient complained of dizziness, blurred vision and numbness on left arm. She was brought to a room and assessed, and vital signs were stable and right after she started having a seizure that lasted for less than a minute. She felt confused and all her left side felt weak, and she could not move limbs. EMS was called and she was transferred to the emergency room by paramedics.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
Cats
Vorherige Impfungen
She stated having an adverse reaction when received Hep A and Influenza in 2018.

VAERS 2705453

SEQIRUS, INC. · INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT) · Charge AU3130B

moderat
Staat
NC
Alter
43,0
Geschlecht
F
Eingang
29.10.2023
Impfdatum
19.10.2023
Beginn
19.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Sleep disorder Tremor Trismus

Symptomtext

While asleep woken up with jaw locked and body shaking. Duration = a couple of minutes. Had second shorter event the next morning 15-20 secs during nap and awakened again. No issues since then.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
IBS
Andere Medikamente
VSL #3, Mag Citrate, Fish Oil, Multivitamins, sulfamethoxazone-tmp
Allergien
Wheat Casin Lactose Bee Stings
Vorherige Impfungen
First Pfizer shot - heart racing age 40

VAERS 2701673

SEQIRUS, INC. · INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT) · Charge AU3130B

moderat
Staat
TX
Alter
50,0
Geschlecht
F
Eingang
25.10.2023
Impfdatum
13.10.2023
Beginn
13.10.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chest pain Dyspnoea Eye swelling Lacrimation increased Pain Respiratory tract congestion Somnolence Swelling of eyelid Throat irritation

Symptomtext

Patient reported to the front desk following discharge and labs reporting that she was experiencing shortness of breath post injection of Flucelvax and Heplisav B. Patient was brought back and had visibly swollen and watery eyes. While walking to exam room she states that she has chest pain. Code orange was called at 1050. Dr. evaluating patient. Patient complains of itchy throat and swollen eyes. Benadryl 50 mg ordered and administered by RN to the LD IM. Patient was placed on 4L O2 via NC Patient remains aaox4 and continues to complain of itching throat and pain with speaking. Solumedrol 125 mg ordered and administered IM to the RD by RN. IV 22g started to R AC by RN. IV flushing well. 1104- O2 decreased to 2L NC. 1110- patient reports eyes and throat feel a little better, but she is groggy and feels congested. Oxygen discontinued and patient continues to saturate at 100 %. Patients husband was notified of allergic reaction and advised to pick patient up from clinic. He states that he is on his way. Patient given water and is able to tolerate with no aspiration. Continued to monitor for improvement while awaiting spouse arrival. IV was discontinued at 1138 with catheter intact and no visible redness or inflammation to VI site. Patient was provided with home care instructions by PA-C: Benadryl 50 mg every 6 hours for the next 24 hours. If unable to tolerate 50 mg then it is ok to take 25 mg. Next dose will be at 1700. Per Dr., she would advise that the patient take Zyrtec Non-Drowsy for the next two days. Patient advised that should she experience shortness of breath, difficulty breathing, mouth/lip/tongue swelling, difficulty speaking, chest pain, facial swelling to call 911. Patient verbalized understanding. Written instructions provided as well. Patient left in stable condition with spouse at 1150. Benadryl 50 mg- NDC: 0641-0376-21 Lot: 042044 Exp: 4/2024 Solumedrol 125 mg- NDC: 0009-0047-25 Lot: GC7790 Exp: 1/2025

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
EKG performed during event.
Aktuelle Erkrankungen
None
Vorgeschichte
Hyperlipidemia
Andere Medikamente
Junel 1/20
Allergien
Cat Hair, Tetracyline
Vorherige Impfungen
-

VAERS 2700165

SEQIRUS, INC. · INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT) · Charge AU3130B

moderat
Staat
KS
Alter
41,0
Geschlecht
F
Eingang
23.10.2023
Impfdatum
19.10.2023
Beginn
19.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Muscular weakness Paraesthesia

Symptomtext

Employee reports a tingling sensation through out body and noticeable hand weakness x 4 days so far.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2696142

SEQIRUS, INC. · INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT) · Charge AU3130B

mild
Staat
MN
Alter
29,0
Geschlecht
F
Eingang
14.10.2023
Impfdatum
12.10.2023
Beginn
13.10.2023
Tage bis Beginn
1,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia

Symptomtext

Patient contacted our office 24 hours of receiving a vaccination. Patient was experiencing joint type pain at the shoulder. Denies radiating pain. Per patient the vaccine was given 2.5 finger width below the acromion process. Director suggested patient use NSAID's and Ice to reduce any swelling. Recommended seeing primary care provider if pain increases. Followed up with Patient 48 hours after. Patient stated the pain has decreased, but not subsided. Patient is taking an NSAID and stated it has helped.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2696133

SEQIRUS, INC. · INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT) · Charge AU3130B

gering
Staat
MN
Alter
53,0
Geschlecht
F
Eingang
14.10.2023
Impfdatum
11.10.2023
Beginn
11.10.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Vaccination error Wrong technique in product usage process

Symptomtext

Medication error- patient was given an injection with no vaccine, the injection only contained air.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vaccination error
Hospital-Tage
-
Labordaten
Director contacted patient and had patient return to the clinic on the same day and he received an accurate full dose of COVID vaccine.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2696132

SEQIRUS, INC. · INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT) · Charge AU3130B

gering
Staat
MN
Alter
31,0
Geschlecht
M
Eingang
14.10.2023
Impfdatum
11.10.2023
Beginn
11.10.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Medication error

Symptomtext

Medication error- patient was given an injection with no vaccine, the injection only contained air.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
Director contacted patient and had patient return to the clinic on the same day and he received an accurate full dose of COVID vaccine.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2683637

SEQIRUS, INC. · INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT) · Charge AU3130B

gering
Staat
WA
Alter
64,0
Geschlecht
M
Eingang
19.09.2023
Impfdatum
18.09.2023
Beginn
18.09.2023
Tage bis Beginn
0,0
Dosis
7+
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event

Symptomtext

None at this time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
None at this time.
Aktuelle Erkrankungen
-
Vorgeschichte
Chronic Pain-Neck /Back hypertension Asbestosis Reactive Airway Disease High Cholesterol Diabetes Mellitus anxiety Insomnia
Andere Medikamente
METFORMIN , LORAZEPAM, AMITRIPTYLINE, TAMSULOSIN, BUSPIRONE , COZAAR
Allergien
LISINOPRIL
Vorherige Impfungen
-